Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 243,574 | 269,907 | 285,053 | 322,399 | 578,157 |
| Receivables | 22,537 | 27,882 | 28,493 | 38,520 | 28,873 |
| Inventories | 45,326 | 46,667 | 49,773 | 50,082 | 50,409 |
| TOTAL | $325,867 | $359,761 | $376,282 | $429,146 | $679,098 |
| Non-Current Assets | |||||
| PPE Net | 158,624 | 162,727 | 166,428 | 164,474 | 164,555 |
| Intangibles | 315,305 | 322,495 | 359,459 | 354,835 | 373,648 |
| Other Non-Current Assets | 49,395 | 51,983 | 57,582 | 59,789 | 60,914 |
| TOTAL | $523,324 | $537,205 | $583,469 | $579,098 | $599,117 |
| Total Assets | $849,191 | $896,966 | $959,751 | $1,008,244 | $1,278,215 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,440 | 5,440 | 5,440 | 5,440 | 5,440 |
| Accounts payable and accrued liabilities | 7,998 | 11,525 | 9,525 | 11,957 | 9,494 |
| Accrued Expenses | 48,136 | 50,202 | 44,603 | 39,574 | 38,498 |
| TOTAL | $61,574 | $69,682 | $63,158 | $56,971 | $63,241 |
| Non-Current Liabilities | |||||
| Long Term Debt | 287,381 | 288,436 | 289,499 | 290,492 | 516,283 |
| Deferred Revenues | N/A | 1,639 | 2,756 | N/A | 1,834 |
| Other Non-Current Liabilities | 57,471 | 68,432 | 66,874 | 72,628 | 129,618 |
| TOTAL | $355,758 | $359,301 | $366,320 | $374,064 | $601,847 |
| Total Liabilities | $417,332 | $428,983 | $429,478 | $431,035 | $665,088 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 255,707 | 255,362 | 254,660 | 254,336 | 252,528 |
| Common Shares | 2,554 | 2,553 | 2,547 | 2,527 | 2,523 |
| Retained earnings | 45,799 | 71,355 | 110,946 | 140,891 | 167,036 |
| Other shareholders' equity | 186,995 | 202,698 | 229,983 | 251,917 | 267,987 |
| TOTAL | $431,859 | $467,983 | $530,273 | $577,209 | $613,127 |
| Total Liabilities And Equity | $849,191 | $896,966 | $959,751 | $1,008,244 | $1,278,215 |